PiSZ alpha-1 antitrypsin deficiency (AATD): pulmonary phenotype and prognosis relative to PiZZ AATD and PiMM COPD. (Q41614676)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26141072%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

title

PiSZ alpha-1 antitrypsin deficiency (AATD): pulmonary phenotype and prognosis relative to PiZZ AATD and PiMM COPD (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26141072%20AND%20SRC:MED&resulttype=core&format=json

chronic obstructive pulmonary disease

18 February 2020

main subject

1 reference

based on heuristic

inferred from title

alpha-1-antitrypsin deficiency

1 reference

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26141072%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Sushanth Vayalapra

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26141072%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

author name string

C E Green

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26141072%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

J A Hampson

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26141072%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

D Mukherjee

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26141072%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

R A Stockley

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26141072%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

language of work or name

English

0 references

publication date

3 July 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26141072%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26141072%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

volume

70

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26141072%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

page(s)

939-945

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26141072%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26141072%20AND%20SRC:MED&resulttype=core&format=json

Genetic variants of alpha1-antitrypsin

18 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2015-206906

The Electrophoretic α;1-Globulin Pattern of Serum in α;1-Antitrypsin Deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2015-206906

The protease inhibitor PI*S allele and COPD: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2015-206906

Estimated numbers and prevalence of PI*S and PI*Z alleles of alpha1-antitrypsin deficiency in European countries.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2015-206906

Serum levels and genotype distribution of α1-antitrypsin in the general population

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2015-206906

Alpha1-antitrypsin determines the pattern of emphysema and function in tobacco smoke-exposed mice: parallels with human disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2015-206906

CT scan appearance, densitometry, and health status in protease inhibitor SZ alpha1-antitrypsin deficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2015-206906

Development of predictive models for airflow obstruction in alpha-1-antitrypsin deficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2015-206906

Relationship of the 2011 Global Initiative for Chronic Obstructive Lung Disease strategy to clinically relevant outcomes in individuals with α1-antitrypsin deficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2015-206906

Detection of emphysema progression in alpha 1-antitrypsin deficiency using CT densitometry; methodological advances

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2015-206906

Outdoor air pollution is associated with rapid decline of lung function in alpha-1-antitrypsin deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2015-206906

Decline in FEV1 among patients with severe hereditary alpha 1-antitrypsin deficiency type PiZ.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2015-206906

Rate of progression of lung function impairment in alpha1-antitrypsin deficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2015-206906

American Thoracic Society/European Respiratory Society statement: standards for the diagnosis and management of individuals with alpha-1 antitrypsin deficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2015-206906

Alpha-1 antitrypsin deficiency targeted testing and augmentation therapy: a Canadian Thoracic Society clinical practice guideline

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2015-206906

Exploring the role of CT densitometry: a randomised study of augmentation therapy in alpha1-antitrypsin deficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2015-206906

Quantum proteolysis by neutrophils: implications for pulmonary emphysema in alpha 1-antitrypsin deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2015-206906

Clarification of the risk of chronic obstructive pulmonary disease in α1-antitrypsin deficiency PiMZ heterozygotes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2015-206906

Alpha-1-antitrypsin deficiency: smoking, decline in lung function and implications for therapeutic trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2015-206906

Decline in FEV1 in patients with PiZ alpha-1-antitrypsin deficiency: the Australian experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2015-206906

Tumor necrosis factor-{alpha} rs361525 polymorphism is associated with increased local production and downstream inflammation in chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2015-206906

The fibrinogen cleavage product Aα-Val360, a specific marker of neutrophil elastase activity in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2015-206906

Aα-Val360: a marker of neutrophil elastase and COPD disease activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2015-206906